Ibrutinib
CHEBI:CHEBI_76612
Definition
A member of the class of acrylamides that is (3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine in which the piperidine nitrogen is replaced by an acryloyl group. A selective and covalent inhibitor of the enzyme Bruton's tyrosine kinase, it is used for treatment of B-cell malignancies.
Chemical Information
- Molecular Formula
- C25H24N6O2
- Molecular Mass
- 440.49710
- Charge
- 0
- SMILES
- Nc1ncnc2n(nc(-c3ccc(Oc4ccccc4)cc3)c12)[C@@H]1CCCN(C1)C(=O)C=C
- InChI
- InChI=1S/C25H24N6O2/c1-2-21(32)30-14-6-7-18(15-30)31-25-22(24(26)27-16-28-25)23(29-31)17-10-12-20(13-11-17)33-19-8-4-3-5-9-19/h2-5,8-13,16,18H,1,6-7,14-15H2,(H2,26,27,28)/t18-/m1/s1
- InChIKey
- XYFPWWZEPKGCCK-GOSISDBHSA-N
Alternative Names
- 1-{(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl}prop-2-en-1-one
- ibrutinib
- ibrutinib
- ibrutinibum
- IMBRUVICA
- PCI 32765
- PCI-32765
- PCI32765
Drug Classification
-
pyrazolopyrimidineView Class →
CHEBI:38669
-
aromatic etherView Class →
CHEBI:35618
-
tertiary carboxamideView Class →
CHEBI:140326
-
aromatic amineView Class →
CHEBI:33860
-
acrylamidesView Class →
CHEBI:22216
-
N-acylpiperidineView Class →
CHEBI:48591
-
t289248
-
t289845
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- DRON_00010000
- 1442981
- oboInOwl#hasDbXref
- Wikipedia:Ibrutinib
- core#notation
- CHEBI:76612
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- listing_expiration_date
- 20241231
- route
- ORAL
- marketing_start_date
- 20131113
- labeler_name
- AbbVie Inc.
- spl_id
- 1f948da4-56f5-8884-e063-6394a90aef9d
- package_ndc
- 11014-0329-3
- package_description
- 1 BAG in 1 DRUM (11014-0329-3) / 31250 TABLET, FILM COATED in 1 BAG
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 1442981
- oboInOwl#hasDbXref
- Wikipedia:Ibrutinib
- oboInOwl#id
- CHEBI:76612
- generic_name
- Ibrutinib HFCC
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT
- dosage_form
- CAPSULE
- product_ndc
- 11014-0329
- brand_name
- Imbruvica
- brand_name_base
- Imbruvica
- application_number
- NDA205552
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_76617
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- core#notation
- CHEBI:76612
- rxcui
- 2611540
- package_marketing_start_date
- 23-JUN-17
- nui
- N0000175076
- pharm_class_epc
- Kinase Inhibitor [EPC]
- pharm_class
- Protein Kinase Inhibitors [MoA]
- pharm_class_moa
- Protein Kinase Inhibitors [MoA]
- active_ingredient_strength
- 560 mg/1
- active_ingredient_name
- IBRUTINIB
- manufacturer_name
- Pharmacyclics LLC
- unii
- 1X70OSD4VX
- spl_set_id
- 0dfd0279-ff17-4ea9-89be-9803c71bab44
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- has_treatment
- http://purl.obolibrary.org/obo/DOID_6354
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect34718
- owl#annotatedSource
- t290465
- owl#someValuesFrom
- t3897960